Viral Trojan horse for combating tuberculosis

Drug Discovery Today

Volumn 7, Issue 6, 2002, Pages 333-335

  Johnston, Nicole ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ENZYME; ENZYME LYSIN; PEPTIDOGLYCAN; PROTEIN; PROTEIN HOLIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BACTERIOPHAGE; CELL VACUOLE; DRUG EFFECT; DRUG POTENCY; ENZYME ISOLATION; MYCOBACTERIUM AVIUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NASOPHARYNX; NONHUMAN; NOTE; STREPTOCOCCUS PNEUMONIAE; TUBERCULOSIS; ARTICLE; CHEMISTRY; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; VIROLOGY;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTERIOPHAGES; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 0037085579     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(02)02222-5     Document Type: Short Survey

References (5)

1. Killing of Mycobacterium avium (MAC) and Mycobacterium tuberculosis (MTb) by a mycobacteriophage delivered by avirulent mycobacteria: A model for phage therapy of intracellular bacterial pathogens
2. Bacteriophage therapy
3. Phage antibacterials make a comeback
4. Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme
5. Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase